Generating iAstrocytes From Human Induced Pluripotent Stem Cells by Combining Low‐Density Passaging of Neural Progenitor Cells and Transcription Factor NFIA Transdifferentiation
Current Protocols · 2024
DOI: 10.1002/cpz1.70049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Protocols, 2024. Verfasst von Patrick Bosco und 5 weiteren Autor:innen. Beteiligte Einrichtung: Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, New York. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Neural Stem Cells, NFI Transcription Factors, Cell Transdifferentiation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Astrocytes are key regulators of central nervous system (CNS) homeostasis, and their dysfunction is implicated in neurological and neurodegenerative disorders. Here, we describe a two‐step protocol to generate astrocytes from human induced pluripotent stem cells (hiPSCs) using a bankable neural progenitor cell (NPC) intermediate, followed by low‐density passaging and overexpression of the gliogenic transcription factor NFIA . A bankable NPC intermediate allows for facile differentiation into both purified neuronal and astrocyte cell types in parallel from the same genetic background, depending on the experimental needs. This article presents a protocol to generate NPCs from hiPSCs, which are then differentiated into hiPSC‐derived astrocytes, termed iAstrocytes. The resulting iAstrocytes express key markers of astrocyte identity at transcript and protein levels by bulk RNA‐Seq and immunocytochemistry, respectively. Additionally, they respond to the inflammatory stimuli poly(I:C) and generate waves of calcium activity in response to either physical activity or the addition of ATP. Our approach offers a simple and robust method to generate and characterize human astrocytes, which can be used to model human disease affecting this cell type. © 2024 Wiley Periodicals LLC. Basic Protocol 1 : Differentiation of hiPSCs to NPCs Basic Protocol 2 : Differentiation of NPCs into iAstrocytes Support Protocol 1 : Molecular validation of iAstrocytes Support Protocol 2 : Calcium imaging‐based validation of iAstrocyte function Support Protocol 3 : Differentiation of NPCs into neurons
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, New York.
- Department of Neurology, Columbia University Irving Medical Center, New York, New York.
- Center for Translational Research in Neurodevelopmental Disease, Columbia University Irving Medical Center, New York, New York.
- Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York.
ORCID-Profile: Andrew A Sproul
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Bosco, P., Akcan, U., Williams, D., Buchanan, H. M., Agalliu, D., & Sproul, A. A. (2024). Generating iAstrocytes From Human Induced Pluripotent Stem Cells by Combining Low‐Density Passaging of Neural Progenitor Cells and Transcription Factor NFIA Transdifferentiation. Current Protocols. https://doi.org/10.1002/cpz1.70049
Vancouver
Bosco P, Akcan U, Williams D, Buchanan HM, Agalliu D, Sproul AA. Generating iAstrocytes From Human Induced Pluripotent Stem Cells by Combining Low‐Density Passaging of Neural Progenitor Cells and Transcription Factor NFIA Transdifferentiation. Current Protocols. 2024. doi:10.1002/cpz1.70049
BibTeX
@article{Bosco2024,
author = {Bosco, Patrick and Akcan, Ugur and Williams, Damian and Buchanan, Heather M and Agalliu, Dritan and Sproul, Andrew A},
title = {Generating iAstrocytes From Human Induced Pluripotent Stem Cells by Combining Low‐Density Passaging of Neural Progenitor Cells and Transcription Factor NFIA Transdifferentiation},
journal = {Current Protocols},
year = {2024},
doi = {10.1002/cpz1.70049}
}
EUVIMED